Why the study?
Does natriuretic peptide (NP)-guided treatment prevent cardiovascular events in people with cardiovascular risk factors (without heart failure)?
Does natriuretic peptide (NP)-guided treatment prevent cardiovascular events in people with cardiovascular risk factors (without heart failure)?
This is a protocol for a Cochrane Review to assess the effects of natriuretic peptide-guided treatment in people with cardiovascular risk factors but without heart failure.
Answers are grounded in this paper and cite their sources.
Protocol for NP-guided therapy review in at-risk patients without HF now underway; will clarify effects on events when completed.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of natriuretic peptide (NP)-guided treatment in people with cardiovascular risk factors (without heart failure).
No takes yet. Share an insight, caveat, or question.
Ryan et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: